What were the key takeaways from Ultralife’s earnings call?

What does Ultralife do and what are its main business segments?

What is Ultralife's gross profit margin?

What is Ultralife's latest dividend and current dividend yield?

Did Ultralife beat or miss consensus estimates last quarter?

What is the market's earnings forecast for Ultralife next quarter?

What is the revenue and EPS growth rate for Ultralife year over year?

What guidance did Ultralife's management provide for the next earnings period?

- **Revenue Growth**: $43.4M (+15.8% YoY) driven by gov defense (+19%) and new product launches. 
- **Margin Challenges**: Gross margin 22.2% (-210bps YoY) due to supply chain issues and lower-margin mix. 
- **Strategic Moves**: 
  - Calgary closure to save $0.8M annually; Electrochem integration for 2026 growth. 
  - 20+ new products in pipeline, including thin cell tech for medical wearables. 
- **Financial Health**: $2.0M Adjusted EBITDA (4.7% of sales); $4.1M debt reduction YTD. 
- **2026 Outlook**: $90.1M backlog (+6.5% QoQ); focus on operational efficiency and new product monetization. 


**【CEO Summary Section】**
- Q3 2025 revenue: $43.4 million (15.8% YoY growth), with an operating loss of $1 million due to one-time costs ($1.1 million for Calgary closure and Electrochem transition). 
- Gross margin challenges: 22.2% (down 210bps YoY) due to supply chain quality issues and lower-margin product mix. 
- Strategic actions: 
  - Calgary facility closure to save $0.8 million annually; production relocated to Houston. 
  - Company-wide rebranding to consolidate under 'Ultralife' identity, reducing redundancy and enhancing global positioning. 
  - Vertical integration with Electrochem cells for oil and gas, seismic, and sonobuoy applications, with 2026 revenue impact. 
- New product pipeline: 
  - $5.2 million BA 53 battery award for 2026 deliveries. 
  - Thin cell technology for medical wearables and tracking devices, with Q4 testing and 2026 production. 
  - Next-gen communication servers for AI/edge computing, with trials underway. 

**【CFO Financial Commentary】**
- **Revenue Breakdown**: 
  - Battery & Energy: $39.9 million (1.9% YoY growth, excluding Electrochem). 
  - Communications: $3.4 million (8.2% YoY growth). 
  - Commercial/Gov Defense split: 65/35 (vs 63/37 YoY). 
- **Gross Profit**: $9.6 million (10.8% YoY growth), but margin decline due to quality issues and lower medical/oil & gas sales. 
- **Operating Expenses**: $10.6 million (29.4% YoY increase), including $1.3 million from Electrochem and $1.1 million one-time costs. 
- **Adjusted EBITDA**: $2.0 million (4.7% of sales), up from $1.9 million YoY. 
- **Liquidity**: $66.9 million working capital; reduced debt by $4.1 million YTD. 

**【Q&A Highlights】**
- No questions asked; management emphasized 2026 growth drivers: 
  - 20+ new products in Communications (e.g., ruggedized server cases, AI edge servers). 
  - Thin cell technology expansion into medical and industrial IoT. 
  - Electrochem vertical integration for pipeline inspection and seismic telemetry. 
  - Reduced North American facilities (from 5 to 3) to improve efficiency. 


Ultralife Corporation(ULBI)-20251118-2025 Q3 Earnings call transcript

Revenue

Sales and Services Revenue

Financing Services Revenue

Other Revenue

Cost of Revenue

Cost of Goods and Services

Cost of Financing Services

Other Cost

Gross Profit

Other Operating Income

Operating Expenses

Selling, General and Administrative Expenses

Selling and Marketing Expenses

General and Administrative Expenses

Research and Development Expenses

Loss on Bad Debts

Loss on Impairment of Other Assets

Loss on Disposal of Assets

Other Operating Expenses

Operating Income

Non-Operating Income (Loss)

Income (Loss) from Affiliates

Income (Loss) from Associates

Income (Loss) from Joint ventures

Gain (Loss) on Other Investment

Gain (Loss) on Change in Fair Value

Gain (Loss) on Foreign Currency Exchange

Other Non-Operating Income (Loss)

Net Interest Expense

Interest Expense

Interest Income

Pretax Income From Continuing Operations

Income Tax Expense

Current Income Tax

Deferred Income Tax

Income Tax Adjustments

Net Income from Continuing Operations

Income from Discontinued Operations

Other Items Before Net Income

Net Income

Net Income Attributable to Minority Interests

Net Income Attributable to Owners of the Company

Preferred Stock Dividends

Other Adjustments

Net Income Attributable to Common Stockholders

Other Comprehensive Income

Total Comprehensive Income

Total Comprehensive Income Attributable to Minority Interests

Total Comprehensive Income Attributable to Owners of the Company

Basic EPS

Basic EPS from Continuing Operations

Basic EPS from Discontinued Operations

Diluted EPS

Diluted EPS from Continuing Operations

Diluted EPS from Discontinued Operations

ULBI

ULBI fundamentals

You can ask Aime